Tommy Joyce is no cinephile. The last movie he saw in a theater was the remake of True Grit nearly a decade ago. Id rather watch squirrels run in the woods than sit through most of what appears on the big screen, he said.
But theres a film that opened Dec. 5 at the Regal Cinemas at Grand Central Mall thats attracting a lot of attention in his community. Dark Waters a legal thriller starring Mark Ruffalo, with a script inspired by a 2016 New York Times article tells the epic story of the DuPont corporations failure to inform residents of the Mid-Ohio Valley of the considerable health risks of a perfluoroalkyl substance [PFAS] called perfluorooctanoic acid, or C8, for its chain of eight carbons.
The chemical was used in DuPonts production of Teflon and other household products at its Washington Works facility just outside Parkersburg, along the Ohio River. C8 is found in nonstick pans, waterproof clothing, stain-resistant carpets, microwave popcorn bags, fast-food wrappers and hundreds of other products. According to a 2007 study, C8 is in the blood of 99.7% of Americans. Its called a forever chemical because it never fully degrades.
DuPont had been aware since at least the 1960s that C8 was toxic in animals and since the 1970s that there were high concentrations of it in the blood of its factory workers. DuPont scientists were aware in the early 1990s of links to cancerous tumors from C8 exposure. But company executives failed to inform the Environmental Protection Agency [EPA] or the public.
Weathered signage on the Point Park floodwall greets passersby in downtown Parkersburg, West Virginia. Photo: Lexi Browning/100 Days in Appalachia
Joyce graduated from Parkersburg High School in 1992, went off and earned three degrees and came home. He now serves as mayor of the city of Parkersburg population: 30,000.
Joyce said hes heard more about his communitys long struggle with corporate environmental malfeasance in the past few weeks than in his previous two and a half years in office. He attributes this to the release of Dark Waters.
Even David-and-Goliath tales often have complicated backstories, and Joyce knows well that such is the case with Parkersburg and DuPont. DuPont has been in the Ohio Valley for 70-plus years, and has been a tremendous employer, he said. Without question, DuPont was the place to work in the Mid-Ohio Valley for a lot of years. Many of his classmates grew up in DuPont families.Though Chemours, a spinoff company of DuPont, now operates the Washington Works plant, DuPont maintains a presence in the community. A DuPont spokesperson provided an overview of its financial and volunteer support initiatives and wrote that the company supports programs and organizations focused on revitalizing neighborhoods and enhancing quality of life; STEM-related initiatives in local schools; and initiatives that help protect the environment through clean-up or restoration efforts and allow for DuPont Washington Works to show we are a leader in minimizing our environmental footprint within the community.
A probable link between C8 and six conditions: testicular cancer, kidney cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension and high cholesterol.
Parkersburg, said Doug Higgs, is the kind of town where everybody knows everybody. Higgs graduated from Parkersburg High a year after Joyce, and Joyces mother, Barbara, taught him Sunday school.
Everybody knows everybodys business, Higgs said, but nobody talked about C8. It was a matter of not wanting to bite the hand that fed you.
Well-paying jobs, great benefits, Little League sponsorships, investments in the arts but at a cost. The hand that fed did clench.
Higgs, now an emergency room physician living in Richmond, Virginia, recalls returning from road trips with his family asleep in the back seat, awakened as they approached home by the familiar waft of chemicals.
Two of the Higgs most immediate neighbors died in their early 50s of renal cell cancer. Higgs father has ulcerative colitis, and his brother received treatment for polycystic kidney disease in high school.
We all have stories of friends and family, neighbors, dying too young or being diagnosed with various medical problems, Higgs said.
He knows, of course, the distinction between correlation and causation. But the high incidence of a range of diseases has staggered this community. Its unfair, Higgs said, that a community should have to perpetually ask what exactly it has been exposed to, and where and when the consequences will end.
An aerial view of Parkersburg, West Virginia, taken from Fort Boreman Park. Photo: Lexi Browning/100 Days in Appalachia
A vehicle slows down at the corner of Fourth and Market streets in Parkersburg, West Virginia. Photo: Lexi Browning/100 Days in Appalachia
DuPonts own documentation specified that C8 was not to be flushed into surface waters, but the company did so for decades. The chemical seeped into the water supplies of the communities of Lubeck and Little Hocking, immediately west of Parkersburg, and the city of Belpre, Ohio, just across the river; and three other water systems.
In 2004, DuPont paid $70 million in a class-action lawsuit and agreed to install filtration plants in the affected water districts. In 2005, it reached a $16.5 million settlement with the EPA for violations of the Toxic Substances Control Act.
Ohio River Communities are Still Coping with Teflons Toxic Legacy
A collective decision was made to use the money won in the class-action suit to conduct an epidemiological study in which nearly 70,000 of the 80,000 plaintiffs stopped into one of six clinics set up throughout the community, provided their medical histories and offered their blood. They were each paid $400.
A science panel, comprised of public health scientists appointed by DuPont and lawyers representing the community, was convened to examine the immense database. In 2012, after seven years of study, the panel released a report documenting a probable link between C8 and six conditions: testicular cancer, kidney cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension and high cholesterol.
In 2015, DuPont spun off its chemical division into a new company called Chemours, which now occupies the Washington Works facility on the Ohio. In 2017, DuPont and Chemours agreed to pay $671 million to settle some 3,500 pending lawsuits.
The Washington Works facility, formerly of DuPont, in Parkersburg, West Virginia, is seen from across the Ohio River. Photo by Lexi Browning/100 Days in Appalachia
You grew up with the fear of DuPont leaving town, said Ben Hawkins. Hawkins was student body president of the Parkersburg High class of 1993. He remembers DuPonts participation in his schools Partners in Education program and riding in parades on DuPont-sponsored floats.
Among Hawkins classmates who have been diagnosed with pancreatic cancer was Mike Cox, a local dentist. Cox, Hawkins and Higgs were among a pack of guys who ran together in high school and stayed close after. Cox was a big Ozzy Osbourne fan, and after a grueling regimen of chemo, Hawkins helped arrange backstage passes to a concert, where Osbourne pulled Cox near and shared his own familys experience with cancer. Post-diagnosis, Cox had begun performing stand-up comedy routines that incorporated flute solos. He died Jan. 28, 2017, at the age of 41, a father of three.
Hawkins, who now lives in the Washington, D.C., area, views his Partners in Education experiences somewhat differently today: It wasnt a partnership; it was a page from a public relations playbook. It was the old hey-look-over-here! move to keep the Teflon dollars flowing into their bank account.
His classmate Beth Radmanesh has similar cynical recollections of DuPonts role in her childhood. Radmanesh grew up less than a mile from the Washington Works plant. Today, she has high cholesterol. Her dad suffers from discoid lupus, causing sores the size of 50-cent pieces on his forehead. Her brother has lupus and had colon cancer, and her sister-in-law has also been diagnosed with lupus.
But Radmanesh said her mom is a proponent of bringing another controversial industry to the valley: fracking for natural gas. I said to her, Weve already had our water contaminated once. Do you want your water [to be] flammable? Because thats what will happen. Her moms response was, Oh, Beth. Thats it. Oh, Beth.
Joe and Darlene Kiger live just a few miles from where Radmanesh grew up. Joe, a physical education teacher, is now quite well known in the community for having raised awareness of the dangers of C8 called the devils piss by some in local water supplies. He and his wife, Darlene, joined the class-action suit that was settled in 2004.
Darlene said that when she and Joe are out around town, there are a lot of whispers behind your back. They dont know what to say. The experience has taken a toll these people all looking at you as bringing this on them, Joe said but theyve never considered leaving. Why would you leave the fight? he said. What would it look like if we packed up?
Theres a lot, Joe said, that DuPont hasnt yet been held accountable for. Earlier this year, Chemours was cited by the EPA for the unregulated release of new chemical compounds from its West Virginia and North Carolina facilities. Im not done yet, Joe said.
Joe Kiger and his wife Darlene Kiger are photographed at their residence in Washington, West Virginia. The Kigers have spent the last two decades working to uncover the impacts and effects of C8 exposure in the region. Weve been through hell over the last 20 years, Joe Kiger said. Photo: Lexi Browning/100 Days in Appalachia
Attorney Harry Deitzler poses for a portrait in his office at Hill, Peterson, Carper, Bee and Deitzler, PLLC, in Charleston, West Virginia. Deitzler was involved in settling the C8 groundwater contamination suit against DuPont in Parkersburg, WV. Photo: Lexi Browning/100 Days in Appalachia
Harry Deitzler served as a lead attorney, among others, in representing the Kigers and tens of thousands of others in the class-action suit. Deitzler was the architect of the decision to use the $70 million to conduct the study.
Parkersburg adopted me in 1975, Deitzler said of his arrival in town. Hed come for a summer internship in the prosecuting attorneys office. The position didnt pay enough to cover his room and board, so he took a job in a bar called Friar Tucks.
By the end of the summer, the community was my family, Deitzler said. I asked the prosecutor if hed hire me as an assistant the next year, and he said, Sure; youll get $6,000 a year. And I said, Thatll be great.
Most people thought I was a recovering alcoholic because I never drank a beer, because I couldnt afford to buy one. Three years later, at 27, he was appointed as prosecuting attorney. Such a wonderful, accepting community.
But, some three decades later, there was a price to pay for taking on DuPont.
There was a misperception that we were trying to put DuPont out of business, and, of course, that was created intentionally by the people in Wilmington, Deitzler said, referring to DuPonts Delaware headquarters. When you have a community of that size, and youve got several thousand people employed there, and multiply that by the families and their relatives its very upsetting. Some folks were unsure of what to make of Deitzler.
Longtime resident Nancy Roettger characterizes the communitys reaction to the revelation of what DuPont had done as a weird mix.
There were women that immediately went out and changed their frying pans, Roettger said. But a lot of those same people decided that Harry Deitzler is a horrible person for his role in exposing DuPont.
Its like, they dont want that frying pan anymore, she said, but they dont want anything negative, and theyre very resentful of the people that stirred up the trouble.
Candace Jones, a neighbor and longtime friend of Roettgers, said she hates the perception that the community has been divided between the DuPonters and everyone else.
Were a community and we all need each other, Jones said. I think its terrible, absolutely horrendous what happened because of decisions made for monetary gain. But I dont believe we can blame the everyday worker. Her father-in-law worked in the Teflon division. He just went to work every day; he provided for [his family].
Candace Jones, a native of Vienna, WV, is photographed downtown. Jones, who has lived in the area for most of her life, recalled DuPonts heavy involvement in the community, from sponsoring community activities and education to employing a great deal of the areas residents. (Photo by Lexi Browning/100 Days in Appalachia
Tracy Danzey grew up in Parkersburg, West Virginia, but now lives on the opposite side of the state in its Eastern Panhandle. Danzey was diagnosed with a rare form of bone cancer that led to the amputation of her leg. Doctors couldnt trace the cause of the cancer, but Danzey believes it was caused by exposure to industrial waste in the waters of Parkersburg that she drank and swam in. Photo courtesy of Seth Freeman Photography
Jones friend Janet Rays husband passed away 16 years ago from pancreatic cancer. He worked for BorgWarner, a manufacturing company on the river. There are about a dozen houses along Rays street in Vienna, a Parkersburg suburb, and I think just about every house during the time Ive lived on the street has been affected by cancer.
Ray said she sometimes feels guilty, thinking that perhaps the livelihood her family has enjoyed as a result of her husbands employment might have caused health problems for others. I certainly hope it didnt.
Tracy Danzey was raised in the quiet of Vienna, there with the Rays, the Joneses, the Higgs family. She now lives on the other side of the state, in West Virginias Eastern Panhandle. Danzey was a competitive swimmer growing up. When not competing, we were on the river we were playing in the creeks. I was always in the water.
Its hard to look back at that time now and see it as idyllic, Danzey said.
At age 20, her thyroid began malfunctioning. Five years later, the socket of her hip shattered while running with her husband. She was diagnosed with an atypical form of bone cancer in her right hip. Her hip and leg had to be amputated; she underwent 18 months of high-dose chemotherapy.
Six leading pathologists from across the country were unable to identify the specific type of cancer. They said its very pathologically unusual. Research has indicated to Danzey, whos a nurse, that pathologically unusual cancers are not uncommonly associated with industrial poisonings.
Danzeys stepfather is retired from DuPont and her stepbrother works on the Teflon line. Yes, it is complicated, her mother, Carolyn Tracewell, said. When her kids were growing up, when someone was hired at DuPont, therewas a celebration the good pay, the benefits, and they did treat their employees well.
But my heart hurts, Tracewell said, to think that her daughters illnesses might be a consequence of all that.
Danzey said her mom mostly just feels pain for me, worries about her stepson and is anxious about the future. Her stepfather wonders if one day his pension check will no longer arrive as a result of all the financial fallout.
None of them argue with Tracy about the source of her illnesses. They know what happened. They allow her to sit in this truth regardless of how it affects them. That means a lot.
Danzey is among those who believe that in regard to perceptions of DuPont in the Parkersburg community, theres a generational divide: Those in their 40s and younger tend to hold a less charitable view than baby boomers and their parents.
There likewise appears to be a generational divide in willingness to drink the water, despite the filtration installed as a result of the settlement.
On the September Saturday afternoon of the annual Parkersburg Paddlefest, kayaker Travis Hewitt, 31, stood ashore of the point where the Ohio meets the Little Kanawha and said that few people he knows truly believe the waters safe. Sure, he paddles in it, but I try not to get it on me and never swims in it. He has a filter installed in his kitchen.
Tommy Joyce, the mayor of Parkersburg, is bullish on West Virginia: Weve got enough coal to light the world, gas to heat the world and brains to run the world.
Fellow Parkersburg High grad Brian Flinn, an engineer, worked for DuPont for eight and a half years; he worked with the raw materials of Teflon. Hes seen both sides. Hes heard, If DuPont leaves, were done. This area will be like most other towns in West Virginia; itll collapse. Hes also aware of the inherent dangers in living within the shadow of the chemical industry. So the sentiment goes, he said, You take the good with the bad, right?
But Danzey is unwilling. I love West Virginia, she said. I really do. I love this state. I dont want to be anywhere else. But she wants better for West Virginians. Industries come into their communities, do well for a while, screw up the environment and then leave.
Its time for something new in West Virginia, she said. Its time for us to expect more.
Tracking the Health Impacts of C8 Exposure
Pondering that future keeps Ben Hawkins up at night. Whats next? Whats next for the community, and where does this end? Or does it? What sort of positivity can come to that community? They need it and they deserve it.
Hawkins asks this: Think about how loyal the people of the Parkersburg community have been to DuPont. What if they had the opportunity to extend that same loyalty to a company thats equally invested in the economic, physical and emotional health of the community?
Thats home and always will be home, Hawkins said of Parkersburg. We came from that community and that community did a lot to shape us. We all want the best for that community whatever form that can take.
##
Top photo: Tracy Danzey grew up in Parkersburg, West Virginia, but now lives on the opposite side of the state in its Eastern Panhandle. Danzey was diagnosed with a rare form of bone cancer that led to the amputation of her leg. Doctors couldnt trace the cause of the cancer, but Danzey believes it was caused by exposure to industrial waste in the waters of Parkersburg that she drank and swam in. Photo courtesy of Seth Freeman Photography
Good River: Stories of the Ohio is a series about the environment, economy and culture of the Ohio River watershed, produced by seven nonprofit newsrooms. To see more, please visit ohiowatershed.org.
- Hannah just thought she was being clumsy, but her bruises were a sign she needed to see her doctor - Daily Mail - October 27th, 2023
- Brent Rutemiller's Cancer In Early Remission After 42 Weeks of Chemotherapy and Stem Cell Transplant - Swimming World Magazine - May 20th, 2022
- Other Notable Health Studies & Research From May 17, 2022 - Study Finds - May 20th, 2022
- Clinton County Relay For Life holds annual event in Riverview Park - Lock Haven Express - May 20th, 2022
- Illinois Is Being Invaded By Worms That Jump A Foot In The Air - 1440wrok.com - May 20th, 2022
- Moderna, J&J COVID Booster Shots Near Authorization. Here's What to Know - NBC Chicago - October 26th, 2021
- GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF- R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research -... - October 26th, 2021
- Merck Provides Update on KEYTRUDA (pembrolizumab) Indication in Third-Line Gastric Cancer in the US - Business Wire - July 6th, 2021
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene - GlobeNewswire - July 6th, 2021
- New global guidelines for stem cell research aim to drive discussions, not lay down the law - The Conversation AU - May 27th, 2021
- Merck (MRK) Granted Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy - StreetInsider.com - May 27th, 2021
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal... - May 27th, 2021
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press - May 27th, 2021
- OPDIVO (nivolumab) in Combination with CABOMETYX (cabozantinib) Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for... - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Opdivo in Combination with Cabometyx Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced RCC -... - February 14th, 2021
- Astellas and Seagen Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced... - February 14th, 2021
- [Full text] Loganin Attenuates Septic Acute Renal Injury with the Participation of | DDDT - Dove Medical Press - February 14th, 2021
- [Full text] Encephalopathy Induced by Preventive Administration of Acyclovir in a | IJGM - Dove Medical Press - February 14th, 2021
- Joint inflammation: Causes, treatment, and symptoms - Medical News Today - February 14th, 2021
- Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz Therapeutic Activity - PRNewswire - February 3rd, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 3rd, 2021
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 4th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - December 4th, 2020
- News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug -... - December 4th, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - Philippine Canadian... - December 4th, 2020
- Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic... - November 11th, 2020
- KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall... - November 11th, 2020
- Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 - Investing News Network - November 11th, 2020
- The great reset: new danger on the horizon - Amandala - November 11th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 11th, 2020
- COVID Drug Given to Trump Developed From Aborted Fetus Cells - Quint Fit - October 10th, 2020
- Lars Jaeger: The Future is Veggie, With 3D Printing - finews.asia - October 10th, 2020
- Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart - Endpoints News - October 10th, 2020
- 5 Deadly Pre-existing Conditions You Could Have Due To COVID-19 - Brumpost - Brumpost - October 10th, 2020
- The Crypto Daily Movers and Shakers October 10th, 2020 - Sports Grind Entertainment - October 10th, 2020
- Coronavirus Tracker: Bexar Co. cases surpass 59,000; Texas hospitalizations trending in the wrong direction - KENS5.com - October 10th, 2020
- Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million - Business Wire - September 24th, 2020
- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations - BioSpace - September 15th, 2020
- Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis - Business Wire - September 15th, 2020
- Braunstein Reflects on the Rise of Quadruplet Therapies in Multiple Myeloma - OncLive - September 9th, 2020
- Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients - GlobeNewswire - September 9th, 2020
- ASX Biotechs Surfing The Covid Story - FN Arena News - August 16th, 2020
- Merck and Eisai Receive Complete Response Letter for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination as First-Line Treatment for... - July 10th, 2020
- FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma - Business... - July 10th, 2020
- Coronavirus PPP Loans In Livingston: Where The Money Went - Livingston, NJ Patch - July 9th, 2020
- Stem Cell Therapy For Kidney Failure. Learn More Now ... - July 7th, 2020
- Anemia in chronic kidney disease - kidneyfund.org - July 7th, 2020
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 7th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -... - June 30th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - PR Web - June 30th, 2020
- Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - Stockhouse - June 30th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that... - June 25th, 2020
- Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System - Business Wire - June 25th, 2020
- First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer - Science Times - May 27th, 2020
- Scientists generate millions of mature human cells, far more than have ever been produced - UB News Center - May 20th, 2020
- Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo - Medical Daily - May 20th, 2020
- Cell therapies trial planned for COVID-19 - Mirage News - May 5th, 2020
- New Study Finds That Wearing Contact Lenses Doesn't Increase Risk of COVID-19 Infection - HealthDay Coronavirus Liveblog - April 26th, 2020
- Israeli COVID-19 treatment with 100% survival rate tested on US patient - The Jerusalem Post - April 15th, 2020
- Stem Cells and Chronic Kidney Disease | Mayo Clinic Center ... - April 11th, 2020
- Kidney Failure | Stem Cell Treatment in Tijuana Mexico - April 11th, 2020
- MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND... - April 11th, 2020
- Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type - Benzinga - April 11th, 2020
- A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. - Columbia Daily Herald - April 7th, 2020
- Researchers test drug that stops early stages of COVID-19 - Open Access Government - April 7th, 2020
- Can cell-based therapy be helpful in tackling coronavirus? - YourStory - March 25th, 2020
- Made-in-space organs could soon be reality - ETHealthworld.com - March 13th, 2020
- What Is the Coronavirus? - WIRED - March 6th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 25th, 2020
- Coronavirus: Doctors try 3,000-year-old Traditional Chinese Medicine (TCM) to treat the virus - Times of India - February 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for... - February 14th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 14th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Cambridge Science Festival showcases new research at the forefront of healthcare and medicine - Cambridge Network - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 8th, 2020
- 4 Crazy but Effective Ways to Save More Money This Year - Nasdaq - February 4th, 2020
- BAME lives to be saved as new organ donation law rolls out - Keep the Faith - January 15th, 2020
- HIV drug resistance an emerging threat, expert warns - DAWN.com - January 10th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as... - January 6th, 2020